Evidence map›Paper›PMID 31408452›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Field Suitability and Diagnostic Accuracy of the Biocentric Open Real-Time PCR Platform for Dried Blood Spot-Based HIV Viral Load Quantification in Eswatini.

Bernhard Kerschberger, Nombuso Ntshalintshali, Qhubekani Mpala, Paola Andrea Díaz Uribe, Gugu Maphalala, Sydney Kalombola, Addissu Bekele Telila, Tiwonge Chawinga, Mukelo Maphalala, Aditi Jani and 7 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bernhard KerschbergerMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Nombuso NtshalintshaliMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Qhubekani MpalaMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Paola Andrea Díaz UribeMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Gugu MaphalalaNational Reference Laboratory, Ministry of Health, Mbabane, Swaziland.
Sydney KalombolaMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Addissu Bekele TelilaMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Tiwonge ChawingaMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Mukelo MaphalalaMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Aditi JaniMédecins Sans Frontières (OCG), Mbabane, Swaziland.
Nomcebo PhugwayoNational Reference Laboratory, Ministry of Health, Mbabane, Swaziland.
Roberto de la TourMédecins Sans Frontières (OCG), Geneva, Switzerland.
Nomxolise NyoniNational Reference Laboratory, Ministry of Health, Mbabane, Swaziland.
Javier GoiriMédecins Sans Frontières (OCG), Geneva, Switzerland.
Sindisiwe DlaminiNational Reference Laboratory, Ministry of Health, Mbabane, Swaziland.
Iza CigleneckiMédecins Sans Frontières (OCG), Geneva, Switzerland.
Emmanuel FajardoAccess Campaign, Médecins Sans Frontières, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the performance and suitability of dried blood spot (DBS) sampling using filter paper to collect blood for viral load (VL) quantification under routine conditions.

methodsWe compared performance of DBS VL quantification using the Biocentric method with plasma VL quantification using Roche and Biocentric as reference methods. Adults (≥18 years) were enrolled at 2 health facilities in Eswatini from October 12, 2016 to March 1, 2017. DBS samples were prepared through finger-prick by a phlebotomist (DBS-1), and through the pipetting of whole venous blood by a phlebotomist (DBS-2) and by a laboratory technologist (DBS-3). We calculated the VL-testing completion rate, correlation, and agreement, as well as diagnostic accuracy estimates at the clinical threshold of 1000 copies/mL.

resultsOf 362 patients enrolled, 1066 DBS cards (DBS-1: 347; DBS-2: 359; DBS-3: 360) were tested. Overall, test characteristics were comparable between DBS-sampling methods, irrespective of the reference method. The Pearson correlation coefficients ranged from 0.67 to 0.82 (P < 0.001) for different types of DBS sampling using both reference methods, and the Bland-Altman difference ranged from 0.15 to 0.30 log10 copies/mL. Sensitivity estimates were from 85.3% to 89.2% and specificity estimates were from 94.5% to 98.6%. The positive predictive values were between 87.0% and 96.5% at a prevalence of 30% VL elevations, and negative predictive values were between 93.7% and 95.4%.

conclusionsDBS VL quantification using the newly configured Biocentric method can be part of contextualized VL-testing strategies, particularly for remote settings and populations with higher viral failure rates.

Indexed as

AdultBlood Specimen CollectionDried Blood Spot TestingEswatiniFemaleHIV-1HIV InfectionsHumansMalePlasmaReal-Time Polymerase Chain ReactionRNA, ViralSensitivity and SpecificitySerologic TestsViral LoadRNA, Viral

Identifiers

PMID31408452
PMCPMC6727953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.